Researchers developed a type of nanoparticle that can “eat debris” related to the plaques that cause heart attacks.

Allogene Therapeutics inked a research collaboration deal with Stanford University to work on a novel nucleic acid delivery system for CAR-T therapy.

Three U.S. senators introduced a resolution in support of a moratorium and other limits on gene editing embryos.